Allosteric modulation company Addex Therapeutics Ltd announced that it has launched a CHF 40 m capital increase with commitments in place from several world-leading healthcare investors,…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now